Physician profile
Curtis E Page
NPI 1922048529
$1,264.55
in general payments reported to CMS, 2019-2025
22 companies · $515 in 2025
The $515 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2023: $251 · 2024: $276 · 2025: $515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $244.54 | 2019-2025 | |
| Caldera Medical, INC | $201.39 | 2025 | |
| Astellas Pharma US INC | $130.88 | 2023-2024 | Veozah |
| Hologic Sales and Service, LLC | $103.19 | 2019-2025 | Acessa Provu System, Myosure Tissue Removal Device |
| Bayer Healthcare Pharmaceuticals INC. | $87.56 | 2019 | |
| Axonics, INC. | $63.55 | 2023-2024 | Axonics, Bulkamid |
| Organon LLC | $52.67 | 2023-2025 | Nexplanon |
| Novo Nordisk INC | $40.72 | 2024-2025 | Wegovy |
| Pfizer INC. | $39.71 | 2023-2025 | |
| Vertex Pharmaceuticals Incorporated | $38.16 | 2025 | |
| Merck Sharp & Dohme LLC | $38.14 | 2024 | Gardasil 9, Gardasil |
| Biogen, INC. | $35.07 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $32.68 | 2023-2024 | Endosee, Paragard T 380a |
| Medtronic, INC. | $24.38 | 2023 | V-Loc 180 |
| Ethicon US, LLC | $23.08 | 2024 | Monocryl |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $18.63 | 2023 | |
| Exact Sciences Corporation | $18.22 | 2023 | Cologuard Collection Kit |
| Laborie Medical Technologies Corp. | $17.30 | 2024 | Kiwi Procup |
| Medline Industries LP | $15.65 | 2023 | |
| Solventum Corporation | $13.90 | 2025 | Prevena |
| Smith+Nephew, INC. | $13.37 | 2023 | Renasys Go V2 Home, Pico 7 |
| Lupin INC. | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Curtis Page listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.